Drug-Induced Anaphylaxis: An Update on Epidemiology and Risk Factors

被引:42
作者
Regateiro, Frederico S. [1 ,2 ,3 ]
Marques, Maria Luis [4 ]
Gomes, Eva Rebelo [4 ]
机构
[1] Ctr Hosp & Univ Coimbra, Allergy & Clin Immunol Unit, Coimbra, Portugal
[2] Univ Coimbra, Fac Med, Inst Immunol, Coimbra, Portugal
[3] Univ Coimbra, Fac Med, Coimbra Inst Clin & Biomed Res iCBR, Coimbra, Portugal
[4] Ctr Hosp & Univ Porto, Allergy & Clin Immunol Dept, P-3000075 Porto, Portugal
关键词
Drug-induced anaphylaxis; Drug allergy; Epidemiology; Risk factors; HYPERSENSITIVITY REACTIONS; FATAL ANAPHYLAXIS; UNITED-STATES; ALLERGY; HOSPITALIZATIONS; PREVALENCE; GUIDELINES; AMERICA;
D O I
10.1159/000507445
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Drug hypersensitivity is one of the most frequent causes of anaphylaxis, particularly in adults and in hospitalized patients. Drug-induced anaphylaxis (DIA) is also associated with more severe outcomes than other anaphylaxis triggers, and drugs are responsible for the majority of deaths due to anaphylaxis. We here review the current knowledge on the incidence, prevalence, drugs involved, mortality, and mortality risk factors for DIA. The incidence of both anaphylaxis and DIA seems to be increasing worldwide. Antibiotics and analgesics are the most frequently reported triggers of DIA. However, the importance of other drug groups should be taken into account, especially in particular settings (e.g., peri-operative and oncology). The identification of risk factors, geographical variables, and drugs associated with higher risk for DIA may improve the outcomes of this entity.
引用
收藏
页码:481 / 487
页数:7
相关论文
共 50 条
  • [31] Update on the epidemiology, risk factors and disease outcomes of osteoarthritis
    O'Neill, Terence W.
    McCabe, Paul S.
    McBeth, John
    BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY, 2018, 32 (02): : 312 - 326
  • [32] Risk Factors for Complications of Drug-Induced Seizures
    Thundiyil J.G.
    Rowley F.
    Papa L.
    Olson K.R.
    Kearney T.E.
    Journal of Medical Toxicology, 2011, 7 (1) : 16 - 23
  • [33] Use of Epinephrine in Patients with Drug-Induced Anaphylaxis: An Analysis of the Beijing Pharmacovigilance Database
    Wang, Tiansheng
    Ma, Xiang
    Xing, Yan
    Sun, Shusen
    Zhang, Hua
    Strumer, Til
    Wang, Bin
    Li, Xiaotong
    Tang, Huilin
    Jiao, Ligong
    Zhai, Suodi
    INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 2017, 173 (01) : 51 - 60
  • [34] Fatal Anaphylaxis: Epidemiology and Risk Factors
    Irene Mikhail
    David R. Stukus
    Benjamin T. Prince
    Current Allergy and Asthma Reports, 2021, 21
  • [35] Economic burden of drug-induced anaphylaxis: what can we do better?
    Cardoso, Barbara
    Moscoso, Teresa
    Morais-Almeida, Mario
    Demoly, Pascal
    Tanno, Luciana K.
    CURRENT OPINION IN ALLERGY AND CLINICAL IMMUNOLOGY, 2022, 22 (04) : 234 - 241
  • [36] Risk factors for drug-induced gingival overgrowth
    Seymour, RA
    Ellis, JS
    Thomason, JM
    JOURNAL OF CLINICAL PERIODONTOLOGY, 2000, 27 (04) : 217 - 223
  • [37] Drug-Induced Anaphylaxis Uncommon in Mastocytosis: Findings From Two Large Cohorts
    Beyens, Michiel
    Sabato, Vito
    Ebo, Didier G.
    Zaghmout, Taleb
    Gulen, Theo
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2024, 12 (07) : 1850 - 1862.e1
  • [38] An update on epidemiology of anaphylaxis in children and adults
    Koplin, Jennifer J.
    Martin, Pamela E.
    Allen, Katrina J.
    CURRENT OPINION IN ALLERGY AND CLINICAL IMMUNOLOGY, 2011, 11 (05) : 492 - 496
  • [39] Tryptase in drug-induced anaphylaxis: the need for acute and baseline values
    Michel, Moise
    Giusti, Delphine
    Klingebiel, Caroline
    Vitte, Joana
    CURRENT OPINION IN ALLERGY AND CLINICAL IMMUNOLOGY, 2024, 24 (05) : 293 - 299
  • [40] Update on the epidemiology, risk factors, and disease outcomes of systemic sclerosis
    Ingegnoli, Francesca
    Ughi, Nicola
    Mihai, Carina
    BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY, 2018, 32 (02): : 223 - 240